HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.
Taoping Wins ~$1.6M Contract From Beijing Huida Dianjian Technology Co., Ltd.; Co Will Supply Its Innovative Smart Rest Stations, Autonomous Street Sweepers, And Other Related Products And Services
Taoping Inc. (NASDAQ:TAOP, the ", Company", or ", Taoping", )))), today announced that it won an RMB 11.1 million (approximately US$1.6 million) contract from Beijing Huida Dianjian Technology Co., Ltd. ("Huida"). Under
